Real-World Experience with Sofosbuvir-Based Regimens in Chronic Hepatitis C - an Analysis from a Nationwide Cohort Study

被引：0
|
作者：
Serejo, Fatima [1 ]
Alexandrino, Paula [2 ]
Castro, Rui Sarmento E. [3 ]
Tavares, Ana Paula [3 ]
Pedroto, Isabel [4 ]
Ferreira, Jose Manuel [4 ]
Serrao, Rosario [5 ]
Santos, Maria Lurdes [5 ]
Da Cunha, Jose Saraiva [6 ]
Valente, Cristina [6 ]
Maltez, Fernando [7 ]
Manata, Maria Jose [7 ]
Calinas, Filipe [8 ]
Marinho, Rui T. [1 ]
Velosa, Jose [2 ]
机构：
[1] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Serv Gastrenterol & Hepatol, Lisbon, Portugal
[2] Hosp Santa Maria, Gastroenterol, Lisbon, Portugal
[3] Hosp Santo Antonio, Infecciol, Porto, Portugal
[4] Hosp Santo Antonio, Gastroenterol, Porto, Portugal
[5] Hosp Sao Joao, Infecciol, Porto, Portugal
[6] Ctr Hosp Univ Coimbra, Infecciol, Coimbra, Portugal
[7] Hosp Curry Cabral, Infecciol, Lisbon, Portugal
[8] Hosp Capuchos, Gastroenterol, Lisbon, Portugal
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
642
引用
收藏
页码：382A / 383A
页数：2
相关论文
共 50 条
  • [41] Effectiveness of sofosbuvir and ledipasvir/sofosbuvir based regimens in hepatitis C virus genotype 3 infection: real-world data from Georgian hepatitis C elimination program
    Tsertsvadze, T.
    Chkhartishvili, N.
    Abutidze, A.
    Sharvadze, L.
    Kerashvili, V.
    Kamkamidze, G.
    Zakalashvili, M.
    Skaggs, B.
    Gvinjilia, L.
    Shadaker, S.
    Nasrullah, M.
    Gamkrelidze, A.
    Kvaratskhelia, V.
    Zeuzem, S.
    Afdhal, N.
    Arora, S.
    Thornton, K.
    Averhoff, F.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S281 - S282
  • [42] Real-World Effectiveness of Sofosbuvir-based Regimens for Hepatitis C Treatment among People Who Inject Drugs and those in Opioid Substitution Therapy in Canada
    Janjua, Naveed Z.
    Darvishian, Maryam
    Chong, Mei Y.
    Ramji, Alnoor
    Yoshida, Eric M.
    Islam, Nazrul
    Butt, Zahid
    Cook, Darrel
    Chapinal, Nuria
    Alvarez, Maria
    Tyndall, Mark
    Krajden, Mel
    HEPATOLOGY, 2017, 66 : 591A - 591A
  • [43] IMPACT OF SOFOSBUVIR-BASED REGIMENS FOR CHRONIC HEPATITIS C INFECTION: A WORK PRODUCTIVITY MODEL FROM MAINLAND CHINA
    Ye, X.
    Xu, X.
    Xie, Q.
    Tang, H.
    Xuan, J.
    VALUE IN HEALTH, 2018, 21 : S6 - S6
  • [44] Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C
    Ogawa, Eiichi
    Nomura, Hideyuki
    Nakamuta, Makoto
    Furusyo, Norihiro
    Kajiwara, Eiji
    Dohmen, Kazufumi
    Kawano, Akira
    Ooho, Aritsune
    Azuma, Koichi
    Takahashi, Kazuhiro
    Satoh, Takeaki
    Koyanagi, Toshimasa
    Ichiki, Yasunori
    Kuniyoshi, Masami
    Yanagita, Kimihiko
    Amagase, Hiromasa
    Morita, Chie
    Sugimoto, Rie
    Kato, Masaki
    Shimoda, Shinji
    Hayashi, Jun
    CANCERS, 2020, 12 (09) : 1 - 13
  • [45] Treatment of chronic hepatitis C genotype 3 with Sofosbuvir-based therpy: a real-life study
    Sandeep Singh Sidhu
    Nirmaljeet Singh Malhi
    Omesh Goyal
    Rupinder Singh
    Usha Dutta
    Rajiv Grover
    JS Sidhu
    Vijay Nanda
    Harmeet Saluja
    Ajesh Bansal
    Gursewak Singh
    Alok Sehgal
    Harsh Kishore
    Simran Sidhu
    Hepatology International, 2017, 11 : 277 - 285
  • [46] Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study
    Wilton, James
    Wong, Stanley
    Yu, Amanda
    Ramji, Alnoor
    Cook, Darrel
    Butt, Zahid A.
    Alvarez, Maria
    Binka, Mawuena
    Darvishian, Maryam
    Jeong, Dahn
    Bartlett, Sofia R.
    Pearce, Margo E.
    Adu, Prince A.
    Yoshida, Eric M.
    Krajden, Mel
    Janjua, Naveed Z.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (03):
  • [47] Three regimens for re-treatment failure of Sofosbuvir-based therapy for chronic hepatitis-C genotype-4: a cohort study
    Shousha, Hend Ibrahim
    Abdelghafour, Reem
    Dabees, Hosam
    AbdelRazek, Wael
    Said, Mohamed
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2022, 64
  • [48] Treatment of chronic hepatitis C genotype 3 with Sofosbuvir-based therpy: a real-life study
    Sidhu, Sandeep Singh
    Malhi, Nirmaljeet Singh
    Goyal, Omesh
    Singh, Rupinder
    Dutta, Usha
    Grover, Rajiv
    Sidhu, J. S.
    Nanda, Vijay
    Saluja, Harmeet
    Bansal, Ajesh
    Singh, Gursewak
    Sehgal, Alok
    Kishore, Harsh
    Sidhu, Simran
    HEPATOLOGY INTERNATIONAL, 2017, 11 (03) : 277 - 285
  • [49] Effectiveness and safety of ledipasvir/ sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan
    Chiu, Hung-Chih
    Chiu, Yen-Cheng
    Yang, Er-Hsiang
    Chang, Ting-Tsung
    Chien, Shih-Chieh
    Wu, I-Chin
    Wu, Chun-Hsien
    Cheng, Pin-Nan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (03) : 983 - 990
  • [50] Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C virus genotype 1 infection in China
    Li, Fan
    Chen, Guofeng
    Shao, Qing
    Ji, Dong
    Li, Bing
    Li, Zhongbin
    Liu, Jialiang
    Liu, Chunxiao
    Wang, Tingting
    Wang, Qiaomin
    Chen, Jing
    Wu, Vanessa
    Wong, April
    Wang, Cheng
    Wang, Yudong
    Lau, George K.
    HEPATOLOGY, 2015, 62 : 959A - 960A
12345